One antisense drug, Isis Pharmaceuticals' (Carlsbad ... application of further chemical modifications such as peptide nucleic acids (PNAs), locked nucleic acid (LNA), and phosporodiamidate ...

Nucleic acid therapeutics use engineered sequences ... there’s no question that siRNAs are way superior to antisense,” says Anastasia Khvorova, an RNA therapeutics specialist at the University ...

Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer, Molecular Therapy - Nucleic Acids (2024). DOI: 10.1016/j.omtn.

Expands DNAbilize® Technology Beyond Oncology into ObesityConference Call to be Held Today at 8:30 A.M. ETHOUSTON, Nov. 15, 2024 (GLOBE ...

Bio-Path Holdings ( (BPTH) ) has released its Q3 earnings. Here is a breakdown of the information Bio-Path Holdings presented to its investors.

A specialised treatment called a Gapmer antisense oligonucleotide (ASO ... Published in Molecular Therapeutics Nucleic Acids, a top journal in the field of nucleic-acid based therapeutics ...